Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients

This clinical trial studies normal breast tissue changes combined with breast magnetic
resonance imaging (MRI) that may suggest the beginnings of cancer development. Using breast
tissue markers in combination with breast imaging such as MRI may help to more accurately
assess a woman's risk of developing breast cancer.

Intervention

Biospecimen Collection, Laboratory Biomarker Analysis, Magnetic Resonance Imaging

Condition

Healthy Subject

Investigators

Victoria Seewaldt, MD, Julie E. Lang, MD, Ruth O'Regan, MD, Terry Hyslop, PhD, Steven K. Clinton, MD, Lisa Yee, MD

See list of participating sites